New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
6

New Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab

The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease.  
medscape.com
over 3 years ago
Preview
0
0

Fewer American Cancer Patients Now Dying in Hospitals

Fewer cancer patients die in the hospital in the United States than in other developed country, but of those who do, more receive chemotherapy during the last 6 months of life than in other nations.  
medscape.com
over 3 years ago
Preview
0
0

Anti-cancer drug treatment for gestational trophoblastic neoplasia (GTN) that does not respond to first-line treatment or that re-occurs | Cochrane

This review concerns anti-cancer drug treatment for women with GTN that does not respond to first-line treatment or that re-occurs. GTN is the name given to a type of cancer that arises from placental tissue following pregnancy, most frequently a molar pregnancy. Molar pregnancies are benign abnormal growths of placental tissue inside the womb. Most are cured by evacuation (D&C) of the womb, however, in up to 20% of cases they become malignant. GTN is usually very responsive to anti-cancer drugs (chemotherapy), however, these drugs can be toxic, therefore the aim of treatment is to achieve a cure with the least side effects. To help doctors select the most appropriate treatment for women with GTN, the disease is classified as low- or high-risk according to specific risk factors.  
cochrane.org
over 3 years ago
3
5
307

Corticosteroids Overview

Review of corticosteroids pathophysiology, pharmacology, and pharmacotherapy  
Dustie Sieg
over 3 years ago
Preview
0
1

First Chemo 'Antidote' Cuts Deaths From 5-FU Toxicity

The first and only approved antidote for severe toxicity related to a chemotherapy overdose dramatically reduces mortality.  
medscape.com
over 3 years ago
Preview
0
2

Must-Know EM Pharmacotherapy Articles of 2015

Dr. Bryan Hayes lists his top 10 must-know EM pharmacotherapy articles of 2015, along with a bonus article and his favorite article of the year.  
aliem.com
over 3 years ago
Preview
0
0

Must-Know EM Pharmacotherapy Articles of 2015

Dr. Bryan Hayes lists his top 10 must-know EM pharmacotherapy articles of 2015, along with a bonus article and his favorite article of the year.  
aliem.com
over 3 years ago
Preview
0
0

FDA Expands Use of Single-Use Antiemetic Fosaprepitant

The FDA has approved single-dose fosaprepitant dimeglumine to prevent delayed nausea and vomiting in patients who receive moderately emetogenic chemotherapy.  
medscape.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago
Preview
1
1

A Survey on Polypharmacy and Use of Inappropriate Medications

In the past, polypharmacy was referred to the mixing of many drugs in one prescription. Today polypharmacy implies to the prescription of too many medications for an individual patient, with an associated higher risk of adverse drug reactions (ADRs) and interactions. Situations certainly exist where the combination therapy or polytherapy is the used for single disease condition. Polypharmacy is a problem of substantial importance, in terms of both direct medication costs and indirect medication costs resulting from drug-related morbidity. Polypharmacy increases the risk of side effects and interactions. Moreover it is a preventable problem. A retrospective study was carried out at Bhopal district (Capital of Madhya Pradesh, India) in the year of September-November 2009 by collecting prescriptions of consultants at various levels of health care. The tendency of polypharmacy was studied and analyzed under the various heads in the survey. Available data suggests that polypharmacy is a widespread problem, and physician, clinical pharmacists and patients are all responsible. These risks can be minimized through identifying the prevalence of this potential problem in a high-risk population and by increasing awareness among patients and healthcare professionals. Physicians and clinical pharmacists have the potential to combating this problem through a variety of interventions such as reducing the number of medications taken, reducing the number of doses taken, increasing patient adherence, preventing ADRs, improving patient quality of life and decreasing facility and drug costs.  
ncbi.nlm.nih.gov
over 3 years ago
Preview
0
0

When Are Breast Cancer Patients at Highest Risk of Venous Thromboembolism? A Cohort Study Using English Health Care Data: Abstract and Introduction

Abstract and Introduction: Women receiving chemotherapy for breast cancer have a clinically important risk for venous thromboembolism; this increased risk immediately after endocrine therapy is restricted to tamoxifen.  
medscape.org
over 3 years ago
Preview
0
0

Updated CINV Guidelines: New Evidence for Change and Practical Issues CME/CE

This activity is intended for oncologists, nurses, and pharmacists, as well as other clinicians who treat patients at risk for or who experience chemotherapy-induced nausea and vomiting (CINV).  
medscape.org
over 3 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
over 3 years ago